Andrew H. Briggs
Has grant
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Quality-of-life in patients with long COVID: harnessing the scale of big data to quantify the health and economic costs
Open Date: 2021-08-01
Close Date: 2023-10-31
Grant: Close
UK evaluation of NHS support post-hospitalisation for COVID19 to inform service development and achieve holistic, integrated, equitable and cost-effective services
Open Date: 2021-06-01
Close Date: 2022-08-31
Grant: Close
A person-centred Needs Informed model of Care for people with HIV (NICHE), to improve wellbeing, mental health and reduce socio-economic disadvantages and stigma.
Open Date: 2021-05-01
Close Date: 2026-04-30
Grant: Close
Glasgow Molecular Pathology (GMP) Node
Open Date: 2015-11-01
Close Date: 2019-10-31
Grant: Close
Glasgow Clinical Research Facility: translating research into benefits for patients.
Open Date: 2015-07-01
Close Date: 2016-03-31
Articles (23)
Year:
2026
Year:
2026
Background Young people’s mental health worsened during and since the coronavirus disease discovered in 2019 pandemic. School environments play a key role in young people’s mental health. Learning Together for Mental Health is a whole-school intervention aiming to promote mental health in secondary schools, adapted from the previous Learning Together intervention which was found effective in reducing bullying and promoting mental health. Objective To adapt Learning Together to increase focus on mental health so producing the Learning Together for Mental Health intervention and evaluate the appropriateness of conducting a Phase III trial of the Learning Together for Mental Health intervention regarding pre-defined progression criteria relating to the intervention and trial methods, and assessing intervention feasibility, reach and acceptability, feasibility of trial measures and procedures, potential mechanisms and possible harms. Design and methods We conducted a feasibility study with baseline and follow-up surveys, process evaluation and economic-evaluation feasibility-testing. Setting and participants One school participated in intervention adaptation. Our feasibility study included four state, mixed-sex secondary schools in southern England (one of which dropped out after baselines and was replaced with another). We recruited 640 year-7 (age 11–12) students at baseline survey and 566 year-10 (age 14–15) students at 12-month follow-up. Baseline and follow-up participants were different groups, as the focus was assessing feasibility for the age groups to be surveyed at baseline and follow-up in a Phase III randomised controlled trial. Twenty staff, 27 year-8 (age 12–13) students and 22 year-10 students participated in qualitative research as did two trainers and one external facilitator. Interventions As part of our feasibility study, all schools received the Learning Together for Mental Health intervention for one academic school year. Main outcome measures Pre-defined criteria for progression to a Phase III trial. Results The intervention was successfully adapted from the previous intervention using public involvement. The trial met all criteria for progression to Phase III. The all-staff and in-depth restorative practice training were implemented with fidelity in all schools and all schools had at least two staff trained in-depth in restorative practice. Curriculum training was delivered with fidelity in three of four schools. The response rate to the baseline (needs) survey across the three participating schools was 79%. Progression required at least two schools to have delivered the curriculum with at least 50% fidelity, which was achieved; one of the two schools which delivered the curriculum reported over 80% fidelity and the other school reported over 75% fidelity. All students and staff across all four schools who completed the action group survey and 93% of senior leadership team members who completed the senior leadership team survey reported that Learning Together for mental health was a good way to promote student Mental Health. Potential mechanisms of action involve promoting student sense of school belonging and practical reasoning and skills. No harms were reported. Trial measures and procedures were feasible and acceptable to implement. Intervention and trial refinement are suggested. Limitations Our study involved a small, purposive sample of schools and students which are not representative of those in England. Conclusions With some minor amendments, Learning Together for Mental Health should be subject to a future Phase III trial of effectiveness. Future work The intervention should be refined by making the curriculum optional and improving materials. Funding This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Public Health Research programme as award number NIHR131594.
Year:
2026
Year:
2026
Year:
2026
Adjuvant chemotherapy for colorectal cancer (CRC) with oxaliplatin and fluoropyrimidine was traditionally given for 6 months but is associated with cumulative peripheral neuropathy. The SCOT study (ISRCTN59757862) was an international, randomized, phase III, noninferiority trial investigating treatment reduction from 6 to 3 months. It originally reported noninferior disease-free survival with reduced toxicity and improved quality of life for 3 months of treatment in 6,088 patients. Here, we report overall survival (OS) with 38 months of additional follow-up. Patients with high-risk stage II and stage III CRC were assigned (1:1) to receive 3 or 6 months of either capecitabine and oxaliplatin (CAPOX) or infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX; bolus and infused fluorouracil with oxaliplatin) that were selected before random assignment. With a median of 113 months follow-up and 1,255 OS events, 5-year OS for 3 versus 6 months of treatment was 82.4% in both groups (hazard ratio, 0.96; 95% CI, 0.8 to 1.07), proving noninferiority of 3 months of treatment. Noninferiority of 3 months of treatment for OS was also shown in 1,087 patients with rectal cancer. The duration effect is regimen-dependent with noninferiority shown for CAPOX but not for FOLFOX. In summary, SCOT has shown noninferiority for OS with 3 months of adjuvant chemotherapy treatment, which should be recommended for most patients.
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2022
Collaborators (54)
Maria Sofia Massa
University of Oxford
Manuela Deidda
University of Glasgow
Steven Hope
University College London
Jagpreet Chhatwal
Assistant Professor
Harvard Medical School
Jeremy Brown
University College London
chris brightling
Professor and Honorary Consultant
University of Leicester
Simon Heller
Professor of Clinical Diabetes
University of Sheffield
Trudie Chalder
King’s College London
Nazir I Lone
Professor
University of Edinburgh
Csaba P. Kovesdy
-
Rachael Evans
Professor of Respiratory Medicine
University of Leicester
Jose Robles-Zurita
PROFESOR PERMANENTE LABORAL
University of Malaga
Hamish McAuley
Academic Clinical Lecturer
University of Leicester
Amanda Adler
University of Oxford
Pilar Rivera-Ortega
Associate Research and Development Director
Manchester University NHS Foundation Trust
Anirban Basu
Fred Hutchinson Cancer Research Center
Sharon B Love
Methodology Lead of Trial Conduct Research
University College London
Aris Angelis
Assistant Professor in Health Economics
London School of Hygiene & Tropical Medicine
john ramage
Professor
King’s College London
Caroline Jolley
Reader in Respiratory Medicine & Physiology
King’s College London
Neisha Sundaram
Assistant Professor
London School of Hygiene & Tropical Medicine
Malcolm Gracie Semple
Professor of Outbreak Medicine and Child Health
University of Liverpool
Charlotte Bolton
Professor of Respiratory Medicine
University of Nottingham
Julio Garcia-Aguilar
Chief Attending Surgeon, Colorectal Service
Memorial Sloan Kettering Cancer Center
Stephen O'Neill
London School of Hygiene & Tropical Medicine
Pardeep Jhund
University of Glasgow
Adrian Levy
Professor and Head
Dalhousie University
rosa legood
Associate Professor
London School of Hygiene & Tropical Medicine
Caroline Kelly
Head of Biostatistics
-
Josep Tabernero
Associate Professor Faculty of Medicine
Universitat de Vic - Universitat Central de Catalunya
Hongtu Zhu
University of North Carolina
Dasha Nicholls
Clinical and Strategic Director, National Audits and Research
Imperial College London
Ewen Harrison
Director. Professor of Surgery and Data Science. Consultant Surgeon
University of Edinburgh
David G Lugo-Palacios
Assistant Professor
London School of Hygiene & Tropical Medicine
J. Wouter Jukema
Leiden University Medical Center
Neil Greening
NIHR Post-Doctoral Fellow, Associate Professor (Clinical)/Honorary Consultant Physician
University of Leicester
Frank Sullivan
Professor of Primary Care Medicine
University of St. Andrews
Frances Mair
Professor
University of Glasgow
Philippe Gabriel Steg
Assistance Publique - Hôpitaux de Paris
Annemarie Docherty
Senior Clinical Lecturer/Intensive Care Consultant
University of Edinburgh
Martin Cowie
Imperial College London
Joanna Porter
University College London
Anna Carnegie
King’s College London
Richard Silverwood
University College London
Ciaran Kohli-Lynch
Assistant Professor
Northwestern University Feinberg School of Medicine
Mark Jones
Professor of Respiratory Medicine
University of Southampton
Ali S Taha
University Hospital
Dan Wootton
Senior Clinical Lecturer
University of Liverpool
Ashish Deshmukh
Professor
Medical University of South Carolina
Elizabeth Allen
London School of Hygiene & Tropical Medicine
David Cunningham
Professor Cancer Medicine
Institute of Cancer Research
Jonathan Fuld
National Clinical Director for Respiratory
NHS England
Nicola McMeekin
Research Associate
University of Glasgow
Olivia Leavy
University of Leicester
Make your next move.
Prepare your application
Review drafts before you send them.